<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>jmedicalcasereports</PublisherName>
      <JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
      <PISSN>I</PISSN>
      <EISSN>S</EISSN>
      <Volume-Issue>Volume 7; Issue 2</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>(Mar-Apr, 2026)</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>-0001</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>Medical Case Reports</ArticleType>
      <ArticleTitle>EUS-Guided Radiofrequency Ablation for Pancreatic Insulinoma: A Case Report</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>1</FirstPage>
      <LastPage>9</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Gabriela</FirstName>
          <LastName>Mintegui</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Zara</FirstName>
          <LastName>Martínez</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>Endogenous hyperinsulinemic hypoglycemia remains a diagnostic challenge requiring precise biochemical and imaging evaluation to determine its etiology. Insulinoma, although rare, is the most common functional pancreatic neuroendocrine tumor. It arises from pancreatic beta cells and is characterized by inappropriate insulin secretion, leading to recurrent hypoglycemia.&#13;
&#13;
We report the case of a 40-year-old woman with recurrent symptomatic hypoglycemia in whom Whipple__ampersandsignrsquo;s triad was documented. Endoscopic ultrasound identified a 13 __ampersandsigntimes; 12 mm lesion in the pancreatic neck, consistent with insulinoma. Given the clinical and anatomical characteristics, endoscopic ultrasound-guided radiofrequency ablation was performed as a minimally invasive therapeutic alternative.&#13;
&#13;
The patient had a favorable short-term outcome, with complete resolution of symptoms, no residual lesion on imaging at 3 months, and normal fasting glucose, insulin, and C-peptide levels at 4 months.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Hypoglycemia,Insulinoma,Radiofrequency Ablation</Keywords>
      <URLs>
        <Abstract>https://www.jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=16213&amp;title=EUS-Guided Radiofrequency Ablation for Pancreatic Insulinoma: A Case Report</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>Crinand;ograve; SF, Napoleon B, Facciorusso A, Lakhtakia S, Borbath I, Caillol F, et al. Endoscopic ultrasound-guided radiofrequency ablation versus surgical resection for treatment of pancreatic insulinoma. Clin Gastroenterol Hepatol 2023; 21: 2834and;ndash;2843.e2.&#13;
&#13;
Cryer PE. Hypoglycemia in diabetes. In: Holt RIG, Cockram C, Flyvbjerg A, Goldstein BJ, editors. Textbook of Diabetes. 4th ed. Oxford: Blackwell Publishing; 2010. p. 528and;ndash;548.&#13;
&#13;
Cryer PE. Hypoglycemia, functional brain failure, and brain death. J Clin Invest 2007; 117: 868and;ndash;870.&#13;
&#13;
de Herder WW, Niederle B, Scoazec JY, Pauwels S, Kloppel G, Falconi M, Kwekkeboom DJ, Oberg K, Eriksson B, Wiedenmann B, Rindi G, Oand;#39;Toole D, Ferone D; Frascati Consensus Conference; European Neuroendocrine Tumor Society. Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology 2006; 84: 183-188.&#13;
&#13;
Debraine Z, Borbath I, Deprez P, Bosly F, Maiter D, Furnica RM. Long-term clinical and radiological outcomes of endoscopic ultrasound-guided radiofrequency ablation of benign insulinomas. Clin Endocrinol (Oxf) 2024; 101: 485and;ndash;490.&#13;
&#13;
Hofland J, Refardt JC, Feelders RA, Christ E, de Herder WW. Approach to the patient: insulinoma. J Clin Endocrinol Metab 2024; 109: 1109and;ndash;1118.&#13;
&#13;
Masciangelo G, Campana D, Ricci C, Andrini E, Rakichevikj E, Fusaroli P, Lisotti A. Endoscopic Ultrasound-Guided Locoregional Treatments for Pancreatic Neuroendocrine Neoplasms. Curr Oncol 2025; 32: 113.&#13;
&#13;
Mintegui G, Cabral S, Casella C. Malignant insulinoma: case report and literature review. Medi Clin Case Rep J 2026; 1: 1564-1568.&#13;
&#13;
Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, Kobayashi M, Hanazaki K. Diagnosis and management of insulinoma. World J Gastroenterol 2013; 19: 829-837.&#13;
&#13;
Placzkowski KA, Vella A, Thompson GB, Grant CS, Reading CC, Charboneau JW, Andrews JC, Lloyd RV, Service FJ. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab 2009; 94: 1069-1073.&#13;
&#13;
Shin JJ, Gorden P, Libutti SK. Insulinoma: pathophysiology, localization and management. Future Oncol 2010; 6: 229and;ndash;237.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>